VHL and hereditary clear cell renal cell carcinoma: We treated mice bearing 786-O tumor xenografts (human VHL deficient renal cell carcinoma) on the 4 described treatment regimens: 1) Conventional dose continuous, 2) high dose intermittent therapy, 3) conventional dose intermittent therapy, and 4) high dose continuous therapy.